BREAKING NEWS
No. 9 OSU tops Mich. 21-10 on 5 Forcier turnovers Forcier's 5 TOs help No. 9 OSU beat Michigan 21-10 Historic health care bill nears key Senate vote Forcier's 5 TOs help No. 9 OSU beat Michigan 21-10 No. 9 OSU tops Mich. 21-10 on 5 Forcier turnovers Dems snare 60 votes to move ahead on health care Ciena takes Nortel unit auction to 2nd day: sources River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries Soccer hair-pulling fuels debate over sport sexism Dems have 60 for health care; Lincoln a 'yes' Dems have 60 for health care; Lincoln a 'yes' Sen. Blanche Lincoln says she'll vote 'yes' on health care test vote, giving Democrats 60. Atlantis astronauts take 2nd spacewalk of mission Ireland battles severe flooding Restored machine to explore mysteries of Big Bang Restored machine to explore mysteries of Big Bang Atheist student groups flower on college campuses A bad month in Afghanistan rippled across the US Hackers leak e-mails, stoke climate debate EPA: Uranium from polluted mine in Nev. wells
AP: Breaking | Alerts | World | US | Politics | Business | Entertainment | Life | Science | Odd | Sports | Tech
FDA: Merck Drug May Have Suicide Link
WASHINGTON (AP) - The Food and Drug Administration said Thursday it is investigating a possible link between Merck's allergy drug Singulair and suicide.
Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
FDA said it is reviewing reports of mood changes, suicidal behavior and suicide in patients who have taken the drug, which was Merck's best-selling product last year.
In the past year Merck has updated the drug's labeling four times to include information on tremors, anxiousness, depression and suicidal behavior reported in some patients.
Singulair had sales of $4.3 billion last year.
Shares of Merck & Co. Inc. fell 10 cents to $44.60 in late morning trading.
Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
